Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Bronchial basal cells · 1 trial · 1 indication
Measured by blood routine test, urine routine test and blood chemistry panels
One of the indicators in pulmonary function test, the extent to which oxygen passes from the air sacs of the lungs into the blood
| Arm | Type | Description |
|---|---|---|
| Bronchial basal cells | EXPERIMENTAL | Transplantation of autologous bronchial basal cells |
| Control | NO_INTERVENTION | Conventional treatment |
| Name | Type | Description |
|---|---|---|
| Bronchial basal cells | BIOLOGICAL | Transplantation of autologous bronchial basal cells |
Inclusion Criteria: * Aged between 40 to 75; * Diagnosed with COPD according the guideline (a. with symptoms of productive cough, sputum production or shortness of breath; b. with poor airflow as indicated by FEV1\<70% predicted value and FEV1/FVC \< 0.7 in pulmonary function test; c. with exclusio...
Bronchial basal cells are an investigational cell therapy being studied for the treatment of Chronic Obstructive Pulmonary Disease (COPD). The therapy involves transplanting autologous bronchial basal cells, which are the patient's own cells, with the goal of repairing or regenerating damaged airway tissue. It is currently in Phase 1 clinical development.
Bronchial basal cells are being developed by cbdMD, Inc., a company traded on the NYSE American under the ticker symbol YCBD. The therapy is in Phase 1 clinical development for Chronic Obstructive Pulmonary Disease.
Bronchial basal cells are in Phase 1 clinical development. The therapy is investigational and has not been approved by regulatory authorities. A Phase 1 clinical trial for the treatment of Chronic Obstructive Pulmonary Disease has been completed.
Bronchial basal cells have been studied in one completed Phase 1 clinical trial, identified as NCT03188627, titled 'Autologous Bronchial Basal Cell Transplantation for Treatment of COPD'. The trial enrolled 24 participants with Chronic Obstructive Pulmonary Disease in China and was not randomized or double-blinded.
Bronchial basal cells refer to the cell therapy used in autologous bronchial basal cell transplantation, a procedure where a patient's own bronchial basal cells are collected and transplanted back to treat Chronic Obstructive Pulmonary Disease. The clinical trial NCT03188627 evaluated this approach in 24 participants.